The use of SMS 201-995 (Somatostatin analogue) in insulinomas: Additional case report and literature review

Hormone Research in Paediatrics

Volumn 29, Issue 5-6, 1988, Pages 211-213

  Hearn, P R ^a   Ahmed, M ^a   Woodhouse, N J Y ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Hypoglycaemia; Insulinoma; Somatostatin analogue SMS 201 995

Indexed keywords

C PEPTIDE; OCTREOTIDE;

AGED; CASE REPORT; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULINOMA; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOMA, ISLET CELL; AGED; ANTINEOPLASTIC AGENTS; BLOOD GLUCOSE; C-PEPTIDE; CASE REPORT; HUMAN; INSULINOMA; MALE; OCTREOTIDE; PANCREATIC NEOPLASMS;

EID: 0023710968     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000181005     Document Type: Article

References (19)

1. Bauer, W.; Briner, U.; Doepfner, W.; Haller, R.; Huguenin, R.; Marbach, P.; Petcher, T.J.; Pless, J.: SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31: 1133-1140 (1982).
2. Alberti, K.G.M.M.; Christensen, N.J.; Christensen, S.E.; Hansen, A.P.; Iversen, J.; Lundbaek, K.; Sayer-Hansen, K.; Orskov, H.: Inhibition of insulin secretion by somatostatin. Lancet ii: 1299-1301 (1973).
3. Boden, G.; Sivitz, M.C.; Owen, O.E.: Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 190: 163-165 (1975).
4. Koerker, D.J.; Ruch, W.; Chideckel, E.: Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184: 482-484 (1974).
5. Bloom, S.R.; Mortimer, C.H.; Thorner, M.O.; Hall, R.; Gomez-Pan, A.; Roy, V.M.; Russell, A.C.G.; Coy, D.H.; Kastin, A. J.; Schally, A.V.: Inhibition of gastrin and gastric acid secretion by growth hormone release inhibiting hormone. Lancet ii: 1106-1109 (1974).
6. Schlegel, W.; Raptis, S.; Harvey, R.F.; Oliver, J.M.; Pfeiffer, E.F.: Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet ii: 166-167 (1977).
7. Kraenzlin, M.E.; Wood, S.M.; Neufeld, M.; Adrian, T.E.; Bloom, S.R.: Effect of long-acting somatostatin analogue, SMS 201-995, on gut hormone secretion in normal subjects. Exper-ientia 41: 738-740 (1985).
8. Anderson, J.V.; Bloom, S.R.: Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995. Scand. J. Gastroent. 21: suppl. 119, pp. 115-128 (1986).
9. Osei, K.; O’Dorisio, T.M.: Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastroenteropancreatic hormones. Ann. intern. Med. 103: 223-225 (1985).
10. Ellison, E.C.; O’Dorisio, T.M.; Benson, G.D.: Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin. Am. J. Surg. 151: 668-675 (1986).
11. Kaloustian, E.: Contrôle métabolique d’un insulinome par un agonistc d’action prolongée de la somatostatine. Presse med. 15: 1881-1882 (1986)
12. Verschoor, P.; Uitterlinden, S.W.; Lamberts, S.W.J.; Del Pozo, E.: On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma. Clin. Endocrinol. 25: 555-560 (1986).
13. Koningsberger, J.C.; Kopperschaar, H.P.F.; Erkelens, D.W.; Thijssen, J.H.H.: Treatment of hypoglycaemia due to insulinoma with somatostatin analogue SMS 201-995. ENEA Symp., Madrid 1986, abstract: somatostatin.
14. Lewis, E.; Tsai, S.; Vinik, A.: Role of long-acting somatostatin analogue (SMS 201-995) in the management of a patient with a benign insulin-secreting adenoma of the pancreas and a post-operative pancreatic fistula. Scand. J. Gastroent. 21: suppl. 119, pp. 217-222 (1986).
15. Hindmarsh, P.; Brook, C.G.D.: Short-term management of nesidioblastosis using the somatostatin analogue SMS 201-995. New Engl. J. Med. 316: 221-222 (1987).
16. Delamarre-van de Waal, H.A.; Veldkamp, E.J.M.; Schrander-Stumpel, C.T.: Long-term treatment of an infant with nesidioblastosis using a somatostatin analogue. New Engl. J. Med. 316: 222-223 (1987).
17. Tong-Hua, L.; Tseng, H.C.; Zhu, Y.; Zhong, S.X.; Chen, J.; Cui, Q.C.: Insulinomas: an immunocytochemical and morphologic analysis of 95 cases. Cancer 56: 1420-1429 (1985).
18. Lamberts, S.W.J.; Uitterlinden, P.; Verschoor, L.; Dongen, K.J. van; Pozo, E. del: Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. New Engl. J. Med. 313: 1576-1580 (1985).
19. Hearn, P.R.; Reynolds, C.; Johansen, K.; Woodhouse, N.J.Y.: Ectopic ACTH induced Cushing’ syndrome: control of cortisol and ACTH levels by SMS 201-995 (sandostatin). Clin. Endocrinol. 28: 181-185 (1988)